Bar Harbor Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EB
AAMU
JWM
P
SAM
OIAM
SFA
TFA
Bar Harbor Wealth Management's DGX Position: Q2 2026 in Review
Bar Harbor Wealth Management increased its Quest Diagnostics (DGX) stake by 0.69% in Q2 2026, buying an estimated $24.9K and bringing the position to 18,585 shares worth $3.94M. The position accounts for 0.21% of the portfolio, ranked #95.
Bar Harbor Wealth Management first reported a position in DGX in Q1 2018 and has held it in 12 quarters since. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Bar Harbor Wealth Management held 18,585 shares of Quest Diagnostics worth $3.94M as of Q2 2026.
- Bar Harbor Wealth Management bought 127 Quest Diagnostics shares in Q2 2026, an estimated $24.9K.
- Quest Diagnostics made up 0.21% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #95 holding.
- Bar Harbor Wealth Management first reported a position in Quest Diagnostics in Q1 2018 and has held it in 12 quarters since.
- 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.